Current Readings: Management of N2 Disease for Lung Cancer

Dennis A. Wigle

doi:10.1053/j.semtcvs.2014.02.008

Current Readings: Management of N2 Disease for Lung Cancer

Dennis A. Wigle

General Thoracic Surgery

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

The optimal management of locally advanced, Stage IIIA NSCLC with N2 level nodal metastases remains challenging and controversial. A number of treatment regimens have been shown safe and effective, but existing clinical trial data frequently falls short of providing guidance to match the right approach with the right patient. We review recent literature in this area and its impact.

Original language	English (US)
Pages (from-to)	67-70
Number of pages	4
Journal	Seminars in thoracic and cardiovascular surgery
Volume	26
Issue number	1
DOIs	https://doi.org/10.1053/j.semtcvs.2014.02.008
State	Published - 2014

Keywords

Chemotherapy
Genomics
Lung cancer
N2 NSCLC
Radiation therapy
Surgery
Targeted therapy

ASJC Scopus subject areas

Surgery
Pulmonary and Respiratory Medicine
Cardiology and Cardiovascular Medicine

Access to Document

10.1053/j.semtcvs.2014.02.008

Cite this

@article{bcaed01863d644b4a1382e14441e622b,

title = "Current Readings: Management of N2 Disease for Lung Cancer",

abstract = "The optimal management of locally advanced, Stage IIIA NSCLC with N2 level nodal metastases remains challenging and controversial. A number of treatment regimens have been shown safe and effective, but existing clinical trial data frequently falls short of providing guidance to match the right approach with the right patient. We review recent literature in this area and its impact.",

keywords = "Chemotherapy, Genomics, Lung cancer, N2 NSCLC, Radiation therapy, Surgery, Targeted therapy",

author = "Wigle, {Dennis A.}",

year = "2014",

doi = "10.1053/j.semtcvs.2014.02.008",

language = "English (US)",

volume = "26",

pages = "67--70",

journal = "Seminars in thoracic and cardiovascular surgery",

issn = "1043-0679",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Current Readings

T2 - Management of N2 Disease for Lung Cancer

AU - Wigle, Dennis A.

PY - 2014

Y1 - 2014

N2 - The optimal management of locally advanced, Stage IIIA NSCLC with N2 level nodal metastases remains challenging and controversial. A number of treatment regimens have been shown safe and effective, but existing clinical trial data frequently falls short of providing guidance to match the right approach with the right patient. We review recent literature in this area and its impact.

AB - The optimal management of locally advanced, Stage IIIA NSCLC with N2 level nodal metastases remains challenging and controversial. A number of treatment regimens have been shown safe and effective, but existing clinical trial data frequently falls short of providing guidance to match the right approach with the right patient. We review recent literature in this area and its impact.

KW - Chemotherapy

KW - Genomics

KW - Lung cancer

KW - N2 NSCLC

KW - Radiation therapy

KW - Surgery

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=84902436067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902436067&partnerID=8YFLogxK

U2 - 10.1053/j.semtcvs.2014.02.008

DO - 10.1053/j.semtcvs.2014.02.008

M3 - Article

C2 - 24952759

AN - SCOPUS:84902436067

SN - 1043-0679

VL - 26

SP - 67

EP - 70

JO - Seminars in thoracic and cardiovascular surgery

JF - Seminars in thoracic and cardiovascular surgery

IS - 1

ER -

Current Readings: Management of N2 Disease for Lung Cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this